Literature DB >> 11203334

Intrathecal use of colistin.

W Vasen, P Desmery, S Ilutovich, A Di Martino.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11203334      PMCID: PMC87428     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  4 in total

1.  Parenteral polymyxin B and colistimethate.

Authors: 
Journal:  JAMA       Date:  1977-04-04       Impact factor: 56.272

2.  Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  A S Levin; A A Barone; J Penço; M V Santos; I S Marinho; E A Arruda; E I Manrique; S F Costa
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

3.  A reassessment of the in-vitro activity of colistin sulphomethate sodium.

Authors:  C R Catchpole; J M Andrews; N Brenwald; R Wise
Journal:  J Antimicrob Chemother       Date:  1997-02       Impact factor: 5.790

4.  [Sensitivity of bacteria of the genus Acinetobacter to antibiotics and ofloxacin].

Authors:  M Fleischer; A Przondo-Mordarska; J Ruczkowska
Journal:  Med Dosw Mikrobiol       Date:  1991
  4 in total
  16 in total

1.  Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii.

Authors:  L A Arroyo; A García-Curiel; M E Pachón-Ibañez; A C Llanos; M Ruiz; J Pachón; J Aznar
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

2.  Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.

Authors:  Aspasia Katragkou; Emmanuel Roilides
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Meningitis due to vancomycin-resistant Enterococcus faecium successfully treated with combined intravenous and intraventricular chloramphenicol.

Authors:  Pablo Gustavo Scapellato; Cecilia Ormazabal; José Luis Scapellato; Edgardo Gabriel Bottaro
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 4.  Polymyxins revisited.

Authors:  David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 5.  Full remission in a patient with catheter-associated ventriculitis due to Acinetobacter baumannii treated with intrathecal and intravenous colistin besides coinfections with other multidrug-resistant bacteria.

Authors:  Rick Dersch; E Robinson; L Beume; S Rauer; W-D Niesen
Journal:  Neurol Sci       Date:  2014-12-11       Impact factor: 3.307

Review 6.  Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review.

Authors:  O Bargiacchi; A Rossati; P Car; D Brustia; R Brondolo; F Rosa; P L Garavelli; F G De Rosa
Journal:  Infection       Date:  2014-04-12       Impact factor: 3.553

Review 7.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

8.  Penetration of colistin into cerebrospinal fluid.

Authors:  S L Markantonis; N Markou; M Fousteri; N Sakellaridis; S Karatzas; I Alamanos; E Dimopoulou; G Baltopoulos
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

Review 9.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

10.  Colistin and polymyxin B: a re-emergence.

Authors:  Sachin Gupta; Deepak Govil; Prem N Kakar; Om Prakash; Deep Arora; Shibani Das; Pradeep Govil; Ashima Malhotra
Journal:  Indian J Crit Care Med       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.